Prescription Drug Monitoring Act of 2021
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in house (Apr 1, 2021)
Prescription Drug Monitoring Act of 2021
This bill imposes, as a condition on certain federal funding for the Prescription Drug Monitoring Program (PDMP), additional notification and reporting requirements concerning prescriptions for potentially addictive drugs.
States or territories that receive this funding must require
- prescribers to consult the PDMP before starting treatment with such drugs, and
- dispensers to report within 24 hours to the PDMP each time they fill a prescription for such drugs.
In addition, the state agency administering a PDMP must analyze reported data for patterns of prescription drug misuse or abuse and provide certain information to prescribers, law enforcement, the public, and other states and territories.
What just happenedApr 2, 2021
Referred to the Subcommittee on Health.
Who’s behind it
- Introduced in HouseApr 1, 2021
- Apr 2, 2021Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Apr 1, 2021IntroReferralH11100
Referred to the House Committee on Energy and Commerce.
Energy and Commerce Committee - Apr 1, 2021IntroReferralIntro-H
Introduced in House
- Apr 1, 2021IntroReferral1000
Introduced in House